{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:14:25Z","timestamp":1783098865401,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Prince of Songkla University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy: Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omton.2024.200837","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T07:15:50Z","timestamp":1718694950000},"page":"200837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Co-stimulation of CD28\/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness"],"prefix":"10.1016","volume":"32","author":[{"given":"Wannakorn","family":"Khopanlert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongsakorn","family":"Choochuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajornkiat","family":"Maneechai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaphat","family":"Jangphattananont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socheatraksmey","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Steinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Sangkhathat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongtep","family":"Viboonjuntra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Terakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-9479","authenticated-orcid":false,"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2024.200837_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omton.2024.200837_bib2","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood-2018-01-785840","article-title":"Chimeric antigen receptor-modified T\u00a0cells: CD19 and the road beyond","volume":"131","author":"Salter","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omton.2024.200837_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T\u00a0cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2024.200837_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omton.2024.200837_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.omton.2024.200837_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.omton.2024.200837_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5415","article-title":"Chimeric antigen receptor T\u00a0cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia","volume":"7","author":"Porter","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2024.200837_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T\u00a0cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200837_bib9","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omton.2024.200837_bib10","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omton.2024.200837_bib11","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1200\/JCO.2017.72.8519","article-title":"Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib","volume":"35","author":"Turtle","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200837_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T\u00a0cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200837_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121322","article-title":"4-1BB enhancement of CAR T function requires NF-\u03baB and TRAFs","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.omton.2024.200837_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","article-title":"Regulatory mechanisms in T\u00a0cell receptor signalling","volume":"18","author":"Gaud","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/eji.1830250515","article-title":"Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39\/CD40 ligand","volume":"25","author":"Bishop","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4049\/jimmunol.169.3.1145","article-title":"Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction","volume":"169","author":"Haxhinasto","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib17","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1074\/jbc.M310628200","article-title":"Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation","volume":"279","author":"Haxhinasto","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omton.2024.200837_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4049\/jimmunol.178.2.671","article-title":"A costimulatory function for T\u00a0cell CD40","volume":"178","author":"Munroe","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.omton.2024.200837_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2024.200837_bib22","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.ymthe.2021.04.038","article-title":"Composite CD79A\/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival","volume":"29","author":"Julamanee","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200837_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T\u00a0cell reporter line: Simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.omton.2024.200837_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymthe.2018.11.015","article-title":"Chimeric Antigen Receptor Library Screening Using a Novel NF-\u03baB\/NFAT Reporter Cell Platform","volume":"27","author":"Rydzek","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2024.200837_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","article-title":"Recent advances and discoveries in the mechanisms and functions of CAR T\u00a0cells","volume":"21","author":"Larson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2024.200837_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200837_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay8248","article-title":"4-1BB costimulation promotes CAR T\u00a0cell survival through noncanonical NF-\u03baB signaling","volume":"13","author":"Philipson","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.omton.2024.200837_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0092-8674(02)00767-5","article-title":"Transcriptional mechanisms underlying lymphocyte tolerance","volume":"109","author":"Maci\u00e1n","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200837_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T\u00a0cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2024.200837_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","article-title":"The transcription factor NFAT promotes exhaustion of activated CD8\u207a T\u00a0cells","volume":"42","author":"Martinez","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2024.200837_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112663","article-title":"NFAT and NF-\u03baB dynamically co-regulate TCR and CAR signaling responses in human T\u00a0cells","volume":"42","author":"Huang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2024.200837_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.904497","article-title":"CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure","volume":"13","author":"Caballero","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/CJI.0000000000000373","article-title":"The Intracellular Domain of CD40 is a Potent Costimulatory Element in Chimeric Antigen Receptors","volume":"44","author":"Levin-Piaeda","year":"2021","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omton.2024.200837_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb9726","article-title":"T cell factor 1: A master regulator of the T\u00a0cell response in disease","volume":"5","author":"Escobar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5- expressing CD8(+) T\u00a0cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omton.2024.200837_bib36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ni.3543","article-title":"CXCR5(+) follicular cytotoxic T\u00a0cells control viral infection in B cell follicles","volume":"17","author":"Leong","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2021.10.016","article-title":"IKZF3 deficiency potentiates chimeric antigen receptor T\u00a0cells targeting solid tumors","volume":"524","author":"Zou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2024.200837_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ccell.2022.09.013","article-title":"Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells","volume":"40","author":"Zhang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2024.200837_bib39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.smim.2016.10.009","article-title":"Metabolic pathways in T\u00a0cell activation and lineage differentiation","volume":"28","author":"Almeida","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.immuni.2016.02.023","article-title":"Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2024.200837_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd4597","article-title":"The pharmacology of second-generation chimeric antigen receptors","volume":"14","author":"van der Stegen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2024.200837_bib42","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2024.200837_bib43","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4049\/jimmunol.2000768","article-title":"Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR-T Cells","volume":"206","author":"Okuno","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96976","article-title":"Enhancing CAR T\u00a0cell persistence through ICOS and 4-1BB costimulation","volume":"3","author":"Guedan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.omton.2024.200837_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106529","article-title":"Design of diversified chimeric antigen receptors through rational module recombination","volume":"26","author":"Si","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.omton.2024.200837_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1182\/blood-2011-07-366419","article-title":"Generation of CD19-chimeric antigen receptor modified CD8+ T\u00a0cells derived from virus-specific central memory T\u00a0cells","volume":"119","author":"Terakura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omton.2024.200837_bib47","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","article-title":"CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in\u00a0vivo persistence and antitumor efficacy of adoptively transferred T\u00a0cells","volume":"66","author":"Kowolik","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200837_bib48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in\u00a0vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omton.2024.200837_bib49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.1402346","article-title":"Target antigen density governs the efficacy of anti-CD20-CD28-CD3 \u03b6 chimeric antigen receptor-modified effector CD8+ T\u00a0cells","volume":"194","author":"Watanabe","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omton.2024.200837_bib50","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/01.HS9.0000848584.91047.e1","article-title":"The novel dual T\/B-cell signaling molecule confers the greater tumoricidal activity and T-cell persistence of CD19 chimeric antigen receptor T-cell","volume":"6","author":"Khopanlert","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.omton.2024.200837_bib51","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1182\/blood-2022-156967","article-title":"Co-Stimulation of CD28\/CD40 Signaling Molecule Potentiates CD19CAR-T Cell Functions and Stemness","volume":"140","author":"Khopanlert","year":"2022","journal-title":"Blood"}],"container-title":["Molecular Therapy: Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T10:46:09Z","timestamp":1728211569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329924000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2950329924000791"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2024.200837","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-stimulation of CD28\/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy: Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2024.200837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200837"}}